World

Irregularities in pharmaceutical procurements identified in Kyrgyzstan

A massive violation in drug purchases at the state agency 'Кыргызфармация' has caused a loss of nearly 138 million Somon.

13 August 2026Tagblick Newsdesk

AI-generatedWritten by an AI system, editorially responsible — how we work

Archive photo: Irregularities in pharmaceutical procurements identified in Kyrgyzstan — Archive photoPhoto: toehk · Flickr · BY-SA

An audit of purchases at the state agency 'Кыргызфармация' has revealed significant irregularities in the procurement of medicines and medical products. According to the audit findings, a total loss of 137 million 950 thousand Somon was identified.

The investigation aimed to verify the legality of the procurements, and the findings indicate that the legal requirements were not adhered to at the aforementioned state agency.

This item was written by an AI system on the basis of the headlines and short teasers of the independently operating newsrooms named below. We disclose this under Art. 50(4), second subparagraph, of Regulation (EU) 2024/1689 (AI Act). Before publication we check origin and verifiability — anything that appears in only one place is not published — as well as language, substance and legally sensitive content. No separate substantive review of each individual item by a natural person takes place; we therefore do not rely on the exemption in Art. 50(4), second subparagraph, of the AI Act. Editorial responsibility for this publication rests with the person named in the imprint (§ 18 Abs. 2 MStV). Please report errors to [email protected] — we will correct or remove the item. Full reports are available from the sources listed.